PierluigiTricociMD

PubMed

• Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction.
  C Michael Gibson, Danielle Duffy, Serge Korjian, M Cecilia Bahit, Gerald Chi, John H Alexander, A Michael Lincoff, Mark Heise, Pierluigi Tricoci, Lawrence I Deckelbaum...> ;The New England Journal of Medicine. 2024 Apr 6
• Effect of CSL112 on Recurrent Myocardial Infarction and Cardiovascular Death: Insights from the AEGIS-II Trial.
  Thomas J Povsic, Serge Korjian, M Cecilia Bahit, Gerald Chi, Danielle Duffy, John H Alexander, Dragos Vinereanu, Pierluigi Tricoci, Sojaita Jenny Mears, Lawrence I Dec...> ;Journal of the American College of Cardiology. 2024 Mar 25
• 6 citations
  ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future.
  Arzu Kalayci, C Michael Gibson, Paul M Ridker, Samuel D Wright, Bronwyn A Kingwell, Serge Korjian, Gerald Chi, Jane J Lee, Pierluigi Tricoci, S Hassan Kazmi, Clara Fit...> ;Current Atherosclerosis Reports. 2022 Jul 1
• 8 citations
  Pharmacometric analyses to characterize the effect of CSL112 on apolipoprotein A-I and cholesterol efflux capacity in acute myocardial infarction patients.
  Bo Zheng, Danielle Duffy, Pierluigi Tricoci, Helen Kastrissios, Marc Pfister, Samuel D. Wright, Andreas Gille, Michael A. Tortorici> ;British Journal of Clinical Pharmacology. 2021 Jun 1
• 43 citations
  Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group...
  C. Michael Gibson, John J.P. Kastelein, Adam T. Phillips, Philip E. Aylward, Megan K. Yee, Michal Tendera, Stephen J. Nicholls, Stuart J. Pocock, Shaun G. Goodman, Joh...> ;American Heart Journal. 2021 Jan 1
• 41 citations
  Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCI.
  Guillaume Marquis-Gravel, Frederik Dalgaard, Aaron D. Jones, Yuliya Lokhnygina, Stefan James, Robert A. Harrington, Lars Wallentin, Philippe Gabriel Steg, Renato D. Lo...> ;Journal of the American College of Cardiology. 2020 Jul 14
• 38 citations
  Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes: The ODYSSEY OUTCOMES Trial
  Deepak L. Bhatt, Andrew Briggs, Shelby D. Reed, Lieven Annemans, Michael Szarek, Vera Bittner, Rafael Diaz, Shaun G. Goodman, Robert A. Harrington, Keiko Higuchi, Flor...> ;Journal of the American College of Cardiology. 2020 May 12
• 38 citations
  Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial
  Harvey D. White, Ph. Gabriel Steg, Michael Szarek, Deepak L. Bhatt, Vera Bittner, Rafael Diaz, Jay M. Edelberg, Andrejs Erglis, Shaun G. Goodman, Corinne Hanotin, Robe...> ;European Heart Journal. 2019 Sep 1
• 73 citations
  Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial
  Philippe Gabriel Steg, Michael Szarek, Deepak L. Bhatt, Vera Bittner, Marie-France Bregeault, Anthony J. Dalby, Rafael Diaz, Jay M. Edelberg, Shaun G. Goodman, Corinne...> ;Circulation. 2019 Jul 9
• 52 citations
  Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report fro...
  Marco Valgimigli, Hector M. Garcia-Garcia, Bernard Vrijens, Pascal Vranckx, Eugene P. McFadden, Francesco Costa, Karen S. Pieper, David M. Vock, Min Zhang, Gerrit Anne...> ;European Heart Journal. 2019 Jul 1
• 17 citations
  Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 Trials
  Alexander C. Fanaroff, Robert M. Clare, Karen S. Pieper, Kenneth W. Mahaffey, Chiara Melloni, Jennifer B. Green, John H. Alexander, W. Schuyler Jones, Robert W. Harris...> ;Circulation. 2019 Feb 12
• 109 citations
  Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial
  Michael Szarek, Harvey D. White, Gregory G. Schwartz, Marco Alings, Deepak L. Bhatt, Vera Bittner, Chern-En Chiang, Rafael Diaz, Jay M. Edelberg, Shaun G. Goodman, Cor...> ;Journal of the American College of Cardiology. 2019 Feb 5
• 20 citations
  The CSL112-2001 trial: Safety and tolerability of multiple doses of CSL112 (apolipoprotein A-I [human]), an intravenous formulation of plasma-derived apolipoprotein A-...
  C. Michael Gibson, Mathieu Kerneis, Megan K. Yee, Yazan Daaboul, Serge Korjian, Ali Poyan Mehr, Pierluigi Tricoci, John H. Alexander, John J.P. Kastelein, Roxana Mehra...> ;American Heart Journal. 2019 Feb 1
• 14 citations
  Stroke Outcomes with Vorapaxar Versus Placebo in Patients with Acute Coronary Syndromes: Insights From the TRACER Trial
  Leo Ungar, Robert M. Clare, Fatima Rodriguez, Bradley J. Kolls, Paul W. Armstrong, Philip E. Aylward, Claes Held, David J. Moliterno, John Strony, Frans Van de Werf, L...> ;Journal of the American Heart Association. 2018 Dec 18
• Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.
  Schwartz, G. G.,Steg, P. G.,Szarek, M.,Bhatt, D. L.,Bittner, V. A.,Diaz, R.,Edelberg, J. M.,Goodman, S. G.,Hanotin, C.,Harrington, R. A.,Jukema, J. W.,Lecorps, G.,Maha...> ;N. Engl. J. Med.. 2018 Nov 08
• 942 citations
  Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled t...
  Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed, Ralph B. D'Agostino, Christopher B. Granger, Nigel P. Jones, Lawrence A. Leiter, Anne E Rosenberg, Kristina N...> ;Lancet. 2018 Oct 27
• 9 citations
  Effects of genetic variation in protease activated receptor 4 after an acute coronary syndrome: Analysis from the TRACER trial.
  Pierluigi Tricoci, Megan L. Neely, Michael J. Whitley, Leonard C. Edelstein, Lukas M. Simon, Chad A. Shaw, Paolo Fortina, David J. Moliterno, Paul W. Armstrong, Philip...> ;Blood Cells, Molecules & Diseases. 2018 Jul 21
• 6 citations
  Incidence, timing, and type of first and recurrent ischemic events in patients with and without peripheral artery disease after an acute coronary syndrome.
  Taku Inohara, Karen S. Pieper, Daniel Wojdyla, Manesh R. Patel, William S Jones, Pierluigi Tricoci, Kenneth W. Mahaffey, Stefan James, John H. Alexander, Renato D. Lop...> ;American Heart Journal. 2018 Jul 1
• 23 citations
  Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention.
  Pierluigi Tricoci, L. Kristin Newby, Robert M. Clare, Sergio Leonardi, C. Michael Gibson, Robert P. Giugliano, Paul W. Armstrong, Frans Van de Werf, Gilles Montalescot...> ;JACC. Cardiovascular Interventions. 2018 May 14
• 10 citations
  Evaluation of potential antiplatelet effects of CSL112 (Apolipoprotein A-I [Human]) in patients with atherosclerosis: results from a phase 2a study.
  Paul A. Gurbel, Udaya S. Tantry, Denise D'Andrea, Thomas Chung, John H. Alexander, Kevin P. Bliden, Samuel D. Wright, Pierluigi Tricoci> ;Journal of Thrombosis and Thrombolysis. 2018 May 1
• 9 citations
  Clinical features and outcomes of patients with type 2 myocardial infarction: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coro...
  Patrícia O. Guimarães, Sergio Leonardi, Zhen Huang, Lars Wallentin, Frans Van de Werf, Philip E. Aylward, Claes Held, Robert A. Harrington, David J. Moliterno, Paul W....> ;American Heart Journal. 2018 Feb 1
• 8 citations
  Obesity, Diabetes, and Acute Coronary Syndrome: Differences Between Asians and Whites.
  Masaya Koshizaka, Renato D. Lopes, L. Kristin Newby, Robert M. Clare, Phillip J. Schulte, Pierluigi Tricoci, Kenneth W. Mahaffey, Hisao Ogawa, David J. Moliterno, Robe...> ;The American Journal of Medicine. 2017 Oct 1
• 26 citations
  Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes
  Joakim Alfredsson, Benjamin Neely, Megan L. Neely, Deepak L. Bhatt, Shaun G. Goodman, Pierluigi Tricoci, Kenneth W. Mahaffey, Jan H. Cornel, Harvey D. White, Keith A.A...> ;Heart. 2017 Aug 1
• 27 citations
  An examination of the relationship between serum uric acid level, a clinical history of gout, and cardiovascular outcomes among patients with acute coronary syndrome
  Neha J. Pagidipati, Connie N. Hess, Robert M. Clare, Axel Åkerblom, Pierluigi Tricoci, Daniel Wojdyla, Robert T. Keenan, Stefan James, Claes Held, Kenneth W. Mahaffey,...> ;American Heart Journal. 2017 May 1
• 22 citations
  Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndrome.
  Connie N. Hess, Robert M. Clare, Megan L. Neely, Pierluigi Tricoci, Kenneth W. Mahaffey, Stefan James, John H. Alexander, Claes Held, Renato D. Lopes, Keith A.A. Fox, ...> ;American Heart Journal. 2017 May 1
• Join now to see all